Tag: FDA compounder restrictions
FDA Petitioned to Prevent Compounders from Producing Ozempic Generics
Novo Nordisk, the pharmaceutical company, has requested the Food and Drug Administration (FDA) to stop compounding pharmacies from producing generic versions of its popular weight loss drug semaglutide. The company believes that the medication...